In severe acute pancreatitis, multiple organ dysfunction syndrome and infectious complications are contributors to high mortality. Interleukin (IL)-15 is a novel cytokine that shares many biologic properties with IL-2. Serum IL-15 levels have not yet been determined in SAP.
Serum IL-15 concentrations were measured in 54 patients with severe acute pancreatitis on admission. The relationships with severity, organ dysfunction, infection, and prognosis were analyzed. Utility of IL-15 for the prediction of clinical outcome was evaluated by receiver operator characteristic (ROC) curve analysis.
Serum IL-15 levels were increased significantly in severe acute pancreatitis (5.8 ± 0.5 pg/mL), and they were correlated with Ranson, APACHE II, and Japanese severity score. Serum IL-15 levels were greater in patients with organ dysfunction, patients with infection, and nonsurvivors (P < 05 each). Incidences of organ dysfunction in patients whose IL-15 levels were less than 3.0, 3.0-5.3, and greater than or equal to 5.3 pg/mL, were 8%, 31%, and 89%, respectively (P < .001). Usefulness of IL-15 for the prediction of organ dysfunction was superior to CRP, IL-6, and IL-8, and it was similar to Ranson, APACHE II, and Japanese severity score. Incidences of infection in patients whose IL-15 levels were less than 5.5, 5.5-9.0, and greater than or equal to 9.0 pg/mL, were 7%, 25%, and 50%, respectively (P < .05). Mortality rates in patients whose IL-15 levels were less than 5.5, 5.5-9.0, and greater than or equal to 9.0 pg/mL, were 11%, 25%, and 80%, respectively (P < .001). Usefulness of IL-15 for the prediction of death was superior to CRP, IL-6, and IL-8.
Serum IL-15 level is a useful predictor of the complications (especially organ dysfunction) and mortality in severe acute pancreatitis.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Relationship of necrosis to organ failure in severe acute pancreatitis.Gastroenterology. 1997; 113: 899-903
- Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis.Br J Surg. 2002; 89: 298-302
- Bacterial contamination of pancreatic necrosis.Gastroenterology. 1986; 91: 433-438
- Acute necrotizing pancreatitis: treatment strategy according to the status of infection.Ann Surg. 2000; 232: 619-626
- Immunosuppression in patients with severe acute pancreatitis.J Gastroenterol. 2006; 41: 779-784
- Peripheral lymphocyte reduction in severe acute pancreatitis is caused by apoptotic cell death.J Gastrointest Surg. 2000; 4: 379-387
- Functional alterations of splenocytes in severe acute pancreatitis.J Surg Res. 2002; 102: 161-168
- Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis.J Gastroenterol. 2006; 41: 158-165
- Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.Science. 1994; 264: 965-968
- Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.J Exp Med. 1994; 180: 1395-1403
- A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.Proc Natl Acad Sci USA. 1994; 91: 4935-4939
- Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.EMBO J. 1994; 13: 2822-2830
- Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor.EMBO J. 1995; 14: 3654-3663
- IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation.J Immunol. 1995; 154: 483-490
- The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis.Nat Med. 1996; 2: 175-182
- IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production.J Immunol. 2000; 164: 3608-3615
- Serum levels of interleukin 15 in patients with rheumatic diseases.J Rheumatol. 2001; 28: 2389-2391
- Serum interleukin-15 is elevated in systemic lupus erythematosus.Rheumatology (Oxford). 2001; 40: 876-881
- Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease.Clin Exp Immunol. 1997; 109: 458-463
- Interleukin-15 production during liver allograft rejection in humans.Transplantation. 2003; 76: 210-216
- Association between increased levels of IL-2 and IL-15 and outcome in patients with early acute respiratory distress syndrome.Eur J Clin Invest. 2002; 32: 862-867
- Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan.Pancreas. 2002; 25: 325-330
- Acute pancreatitis: value of CT in establishing prognosis.Radiology. 1990; 174: 331-336
- Prognostic signs and the role of operative management in acute pancreatitis.Surg Gynecol Obstet. 1974; 139: 69-81
- APACHE II: a severity of disease classification system.Crit Care Med. 1985; 13: 818-829
- Decision-making studies in patient management.N Engl J Med. 1971; 284: 416-424
- Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems.Clin Chem. 1981; 27: 1569-1574
- Prognostic factors in acute pancreatitis.J Clin Gastroenterol. 2002; 34: 167-176
- A critical evaluation of laboratory tests in acute pancreatitis.Am J Gastroenterol. 2002; 97: 1309-1318
- Increased IL-15 production of muscle cells in polymyositis and dermatomyositis.Int Immunol. 2002; 14: 917-924
- Interleukin-15 increases hepatic regenerative activity.J Hepatol. 2006; 45: 410-418
- IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis.J Clin Invest. 2002; 109: 951-960
- Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.Hepatology. 2006; 43: 1211-1219
- Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis.J Infect Dis. 2003; 187: 1442-1451
- IL-15 protects intestinal epithelial cells.Eur J Immunol. 2006; 36: 2691-2699
Accepted: May 5, 2007
Supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan, and Grant-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan.
© 2007 Mosby, Inc. Published by Elsevier Inc. All rights reserved.